Merit Medical Systems | MMSI - Ebitda


Merit Medical Systems reported $104.39M in EBITDA for its fiscal quarter ending in June of 2026.





Ebitda Change Date
3M USD 2.22B 566M Sep/2026
Abbott USD 2.43B 844M Mar/2026
AngioDynamics USD 5.94M 3.78M Sep/2025
Anika Therapeutics USD 4.54M 3.67M Dec/2025
AtriCure USD 27.28M 10.21M Jun/2026
Baxter International USD 309M 756M Mar/2026
Becton, Dickinson and Co. USD 1.71B 1B Jun/2026
Boston Scientific USD 1.63B 27M Jun/2026
Cooper Companies USD 67.9M 255.5M Mar/2026
Dexcom USD 388.7M 24.2M Jun/2026
Edwards Lifesciences USD 555.6M 485.5M Mar/2026
Globus Medical USD 279.84M 48.01M Jun/2026
Haemonetics USD 96.17M 91.87M Jun/2026
ICU Medical USD 110.03M 11.35M Jun/2026
Insulet USD 199.8M 18.1M Jun/2026
Integra LifeSciences USD 79.79M 1.37M Sep/2026
J&J USD 8.99B 721M Jun/2026
Medtronic USD 2.63B 174M Jun/2026
Merit Medical Systems USD 104.39M 10.97M Jun/2026
Olympus JPY 46.26B 2.85B Jun/2026
Pfizer USD 6.01B 18M Jun/2026
STAAR Surgical USD 20M 387K Jun/2026
Stryker USD 1.93B 357M Jun/2026
Tandem Diabetes Care USD 6.42M 3.69M Jun/2026
Teleflex USD 122.91M 47.28M Jun/2026
Terumo JPY 116.67B 58.79B Jun/2026
Zimmer Biomet Holdings USD 830.5M 190.4M Jun/2026